Cobar, Freya Venventia .
HRN: 21-22-12 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/29/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/29/2022
06/04/2022
IVT
40mg
Q24
Pcap C
Waiting Final Action
Indication: Type of Infection: Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes